Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
210035152 210013797 0 96.1 Curative (C) null 2018-05-19 PACLITAXEL N N 210029239 CLARITY TRIAL
210035153 210013801 null 53.5 Curative (C) 2019-06-24 2019-10-02 Enzalutamide N N 210029407 DHAP
210035154 210013804 1.71 88.4 Curative (C) 2016-02-06 2016-11-13 DOXORUBICIN N N 210029552 TRASTUZUMAB
210035155 210013807 0.85 91.2 Curative (C) 2015-12-16 2016-01-14 Irinotecan + Temozolomide Y null 210029666 CLARITY TRIAL
210035156 210022624 1.73 0 Curative (C) 2019-02-25 2019-04-03 MERCAPTOPURINE + METHOTREXATE + VINCRISTINE N N 210030225 CARFILZOMIB
210035157 210022628 1.63 49 null 2018-12-27 2019-04-24 CLL210 TRIAL Y N 210030551 BEAM
210035158 210013836 0 87.4 Palliative (P) 2017-10-26 2018-02-02 Packer Maintenance Regimen N N 210031093 ABVD
210035159 210013841 1.54 34 Palliative (P) 2017-07-30 2017-07-30 Oxaliplatin + Modified de Gramont Y N 210031205 IMMUNOGLOBULIN
210035160 210013844 1.53 89.6 Palliative (P) 2018-10-12 2018-11-04 CYTARABINE + ETOPOSIDE N N 210031222 DOXORUBICIN
210035161 210013851 1.7 null Palliative (P) 2017-06-12 2017-06-12 CNS LGG Irinotecan & Bevacizumab N N 210031639 CYTARABINE + RITUXIMAB
210035162 210028214 null 93 Curative (C) 2018-09-03 2018-09-07 IDARUBICIN 02 N 210032710 ABVD
210035163 210013881 1.66 68.2 Palliative (P) null 2017-11-01 FLUDARABINE N N 210033322 UKALL 60+ TRIAL
210035164 210013900 1.46 59 Palliative (P) 2019-03-03 2019-03-03 FLUDARABINE N N 210033837 IMMUNOGLOBULIN
210035165 210028225 1.75 99.2 Curative (C) 2020-04-21 2020-04-28 Cytarabine intrathecal Y N 210034315 OFATUMUMAB
210035166 210022683 1.63 17.5 null 2019-11-30 2019-11-30 PACLITAXEL 02 N 210034391 CYCLOPHOSPHAMIDE HIGH DOSE
210035167 210013931 null 50 Curative (C) 2018-02-15 2018-09-16 FLAG N null 210035201 ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE
210035168 210013941 1.68 66.7 null 2016-06-22 2016-07-26 Irinotecan + Modified De Gramont N N 210035533 ALL MAINTENANCE
210035169 210013952 1.67 82.3 Curative (C) 2018-02-17 2018-02-17 CYTARABINE + ETOPOSIDE 2 Y 210036454 UKALL 60+ TRIAL
210035170 210013960 1.7 76.1 Curative (C) 2019-10-07 2020-04-14 CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine 02 N 210036496 PEMETREXED
210035171 210022719 null 64 Adjuvant (A) 2018-11-18 2019-06-07 Packer Maintenance Regimen N null 210037672 NHL 2003
210035172 210013982 1.58 95.5 Curative (C) 2020-03-18 2020-03-21 DASATINIB + IDARUBICIN + VINCRISTINE N N 210037675 CYTARABINE
210035173 210013989 0 54 Adjuvant (A) 2018-08-12 2018-08-12 Carboplatin + Pemetrexed 2 N 210038079 CYTARABINE
210035174 210013995 1.79 47 Curative (C) 2018-09-22 2018-09-22 CARBOPLATIN + ETOPOSIDE + VINCRISTINE SULPHATE N N 210038641 CYCLOPHOSPHAMIDE HIGH DOSE
210035175 210028255 null 95 Disease modification (D) 2015-03-04 2015-03-04 Lenalidomide 25mg (Cycle 1 to 25) N null 210039506 PENTOSTATIN + RITUXIMAB
210035176 210014015 0 16.2 Curative (C) 2015-04-07 2018-03-03 Cisplatin + Vinorelbine (IV) 2 N 210040040 ALL
210035177 210014036 0 68 Curative (C) 2017-10-23 2018-01-15 TAVAREC N Y 210041159 CLL210 TRIAL
210035178 210014041 1.57 82.3 Curative (C) 2017-05-02 2017-06-14 CYCLOPHOSPHAMIDE + ETOPOSIDE + NELARABINE N N 210041453 MITOMYCIN INTRAVESICULAR
210035179 210014047 null null Disease modification (D) 2020-02-03 2020-02-06 Alemtuzumab + Cyclophos TBI Allo N null 210041755 IDARUBICIN
210035180 210028266 1.56 78.6 Unknown (U) 2019-01-16 2019-01-16 CARBOPLATIN + VINORELBINE N null 210041781 ALEMTUZUMAB + CYCLO + FLUDARABINE
210035181 210014057 1.87 13.7 Disease modification (D) 2016-04-11 2016-04-19 CISPLATIN + ETOPOSIDE N N 210042047 OBINUTUZUMAB
210035182 210014080 1.82 69.95 Curative (C) 2018-08-10 2018-09-08 Bortezomib + MELPHALAN 02 N 210034307 DAUNORUBICIN + VNCRISTINE
210035184 210032406 1.78 90.2 Palliative (P) 2016-05-14 2016-05-14 TEMOZOLOMIDE 02 N 210000163 TEMOZOLOMIDE
210035185 210004327 1.55 98 Disease modification (D) 2015-03-21 2015-05-06 Temozolomide 200mg/m2 2 N 210000208 TEMOZOLOMIDE
210035186 210004346 1.75 92 Adjuvant (A) 2013-06-03 2014-07-10 TEMOZOLOMIDE 02 N 210000265 TEMOZOLOMIDE
210035187 210024686 1.78 98.6 Adjuvant (A) 2018-03-30 2018-03-31 Temozolomide 200mg/m2 2 N 210000286 TEMOZOLOMIDE
210035188 210004377 1.74 79.1 Palliative (P) 2017-10-16 2018-03-09 TEMOZOLOMIDE N N 210000395 TEMOZOLOMIDE
210035189 210032421 1.8 73.4 Curative (C) 2017-02-17 2017-08-21 TEMOZOLOMIDE N N 210000497 TEMOZOLOMIDE
210035190 210004401 1.72 118.9 Adjuvant (A) 2014-05-14 2014-05-14 TEMOZOLOMIDE 02 N 210000561 TEMOZOLOMIDE
210035191 210004406 1.7 null Curative (C) null 2016-11-19 Temozolomide 200mg/m2 N N 210000602 TEMOZOLOMIDE
210035192 210038311 null 89 Adjuvant (A) 2017-01-28 2017-02-18 TEMOZOLOMIDE 02 N 210000612 TEMOZOLOMIDE
210035193 210004408 1.75 79 Curative (C) 2016-03-10 2016-03-11 TEMOZOLOMIDE 02 N 210000663 TEMOZOLOMIDE
210035194 210029445 1.59 88.8 Adjuvant (A) 2017-03-04 2017-03-04 TEMOZOLOMIDE 02 N 210000818 TEMOZOLOMIDE
210035195 210024739 1.77 76.9 Adjuvant (A) 2014-05-20 2014-08-25 Temozolomide 200mg/m2 N N 210001063 TEMOZOLOMIDE
210035196 210037751 1.7 80 Curative (C) 2014-10-21 2015-03-19 Temozolomide 200mg/m2 N Y 210001064 TEMOZOLOMIDE
210035197 210024744 1.91 74.1 Adjuvant (A) 2015-10-15 2016-05-03 Temozolomide 200mg/m2 02 null 210001190 TEMOZOLOMIDE
210035198 210004511 1.67 46.2 Palliative (P) 2018-05-08 2019-10-31 TEMOZOLOMIDE N null 210001305 TEMOZOLOMIDE
210035199 210029475 1.6 65.8 Palliative (P) 2014-09-03 2014-09-30 TEMOZOLOMIDE N N 210001469 TEMOZOLOMIDE
210035200 210032466 1.7 94.2 null 2015-09-21 2016-01-18 TEMOZOLOMIDE null null 210001570 TEMOZOLOMIDE
210035201 210029482 1.86 null Adjuvant (A) 2017-08-27 2017-11-27 Temozolomide 200mg/m2 N N 210001572 TEMOZOLOMIDE
210035202 210004563 1.62 54.9 Palliative (P) 2016-07-26 2016-08-07 Temozolomide 200mg/m2 02 N 210001686 TEMOZOLOMIDE